[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-368825-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-368825-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","micro-rna-in-colorectal-cancerpotential-diagnostic-and-prognostic-markers-an-updated-review","Micro RNA in Colorectal Cancer—Potential Diagnostic and Prognostic Markers - An Updated Review","","Colorectal cancer (CRC) remains among the deadliest and most common malignancies, and late-stage diagnosis often limits treatment options. Growing evidence supports microRNAs (miRNAs) as regulators of gene expression with both tumor-suppressive and oncogenic functions in CRC. miRNAs affect key processes including EMT, proliferation and migration, apoptosis, autophagy, and therapy response. Clinically, they are emerging as diagnostic and prognostic biomarkers that may guide treatment selection and patient stratification, while ongoing work continues to clarify their full medical potential.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/micro-rna-in-colorectal-cancerpotential-diagnostic-and-prognostic-markers-an-updated-review/368825/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/micro-rna-in-colorectal-cancerpotential-diagnostic-and-prognostic-markers-an-updated-review/368825.png","ImageObject",300,407,{"name":42,"@type":43},"Jasmine","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-07","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why are microRNAs (miRNAs) considered important in colorectal cancer?","Question",{"text":63,"@type":64},"miRNAs modulate gene expression and influence tumor-related processes such as EMT, proliferation and migration, apoptosis, and autophagy in colorectal cancer.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How can miRNAs support CRC screening, diagnosis, and prognosis?",{"text":68,"@type":64},"Emerging studies indicate miRNAs can function as predictive and prognostic biomarkers, including early diagnostic markers in accessible samples.",{"name":70,"@type":61,"acceptedAnswer":71},"What role does DNA methylation play in CRC-related miRNA biomarkers?",{"text":72,"@type":64},"DNA methylation, especially promoter hypermethylation, can silence tumor-suppressive miRNAs. Aberrant methylation patterns are associated with CRC development and can be detected even in early or non-invasive samples.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},368825,1790221930,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":99,"preview_page_count":33,"preview_urls":145},2336478487870,"https://ap-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","Review  \nMicro RNA in Colorectal Cancer—Potential Diagnostic and Prognostic Markers—An Updated Review  \nWeronika Paja˛k 1, Jakub Kleinrok 1, Joanna Pec 2, Karolina Michno 3, Jan Wojtas 2, Miłosz Badach 1, Barbara Teresi ´nska 2 and Jacek Baj 2, *  \nAcademic Editor: Cristina Peña  \nReceived: 2 July 2025  \nRevised: 24 August 2025  \nAccepted: 2 September 2025  \nPublished: 4 September 2025  \nCitation: Paja˛k, W.; Kleinrok, J.; Pec, J.; Michno, K.; Wojtas, J.; Badach, M.; Teresi ´nska, B.; Baj, J. Micro RNA in Colorectal Cancer—Potential Diagnostic and Prognostic Markers—An Updated Review. Int. J. Mol. Sci. 2025, 26, 8615. [https://](https://)[ ](https://)[doi.org/10.3390/ijms26178615](doi.org/10.3390/ijms26178615)  \n[Copyright:](Copyright:) © 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://creativecommons.org/](https://creativecommons.org/)[ ](https://creativecommons.org/)[licenses/by/4.0/](licenses/by/4.0/)) .  \n1 Department of Forensic Medicine, Medical University of Lublin, Jaczewskiego 8b, 20-090 Lublin, Poland; [wapajak@gmail.com](wapajak@gmail.com) (W.P.); [klejs.90@gmail.com](klejs.90@gmail.com) (J.K.); [mimbad@interia.pl](mimbad@interia.pl) (M.B.)  \n2 Department of Correct, Clinical and Imaging Anatomy, Medical University of Lublin, Jaczewskiego 4, 20-090 Lublin, Poland; [apec1410@gmail.com](apec1410@gmail.com) (J.P.); [jan.wojtas7@gmail.com](jan.wojtas7@gmail.com) (J.W.); [b.teresinska2@gmail.com](b.teresinska2@gmail.com) (B.T.)  \n3 Faculty of Medicine, Medical University of Lodz, al. Tadeusza Kosciuszki 4, 90-419 Lodz, Poland; [karolina.michno@stud.umed.lodz.pl](karolina.michno@stud.umed.lodz.pl)  \n* [Correspondence: jacek.baj@umlub.pl](Correspondence: jacek.baj@umlub.pl)  \nAbstract  \nColorectal cancer (CRC) is one of the deadliest and most frequently occurring cancers worldwide. Often diagnosed in advanced stages, it requires more challenging treatment. However, emerging studies highlight the possible role of microRNAs (miRNAs) in the screening, diagnosis, and prognosis of CRC. MiRNAs modulate gene expression and can play both roles in tumor suppressors and oncogenes. In CRC, they influence epithelial– mesenchymal transition (EMT), cell proliferation and migration, apoptosis, autophagy, and patients’ treatment response. In clinical applications, they can be used as predictive and prognostic biomarkers as well as for matching the most suitable treatments. Despite its growing popularity, there is still much to discover about their potential usage in medicine.  \nKeywords: colorectal cancer; diagnostic markers; prognostic markers; microRNA  \n1. Introduction  \nCRC places itself in the top three most common and malignant cancers worldwide. Posing a significant challenge, it demands a comprehensive treatment approach [1–4] . Therefore, early detection is crucial, leaving space for researchers to find the most suitable screening, diagnostic, and prognostic markers. During the last decade, multiple studies regarding the possible role of miRNAs have emerged [5] . MiRNAs are short, non-coding sequences of approximately 22 nucleotides, which modulate gene expression. They are present in different biological samples, which makes them more accessible [6] . A great number of studies proved their role in the occurrence and progression of various cancers including CRC, brain cancer, lung cancer, and breast cancer [7–11] . MiRNAs bind to the 3′ untranslated region (3′UTR) of their target genes, therefore they can regulate various functions in cancer cells, acting either as tumor suppressors or oncogenes. They are involved in key cellular processes such as cell proliferation and migration, autophagy, apoptosis, metabolic reprogramming, EMT, and the response to radiation therapy. MiRNAs have already shown potential in clinical oncology as valuable biomarkers. Abnormal expression patterns of","cbCainSFEH7stzt5","https://ap.wps.com/l/cbCainSFEH7stzt5","pdf",940673,24,"English","# Abstract\n# Keywords\n# Introduction\n## MicroRNAs in colorectal cancer\n## Epigenetic regulation and DNA methylation\n## Clinical and therapeutic implications","[{\"question\":\"Why are microRNAs (miRNAs) considered important in colorectal cancer?\",\"answer\":\"miRNAs modulate gene expression and influence tumor-related processes such as EMT, proliferation and migration, apoptosis, and autophagy in colorectal cancer.\"},{\"question\":\"How can miRNAs support CRC screening, diagnosis, and prognosis?\",\"answer\":\"Emerging studies indicate miRNAs can function as predictive and prognostic biomarkers, including early diagnostic markers in accessible samples.\"},{\"question\":\"What role does DNA methylation play in CRC-related miRNA biomarkers?\",\"answer\":\"DNA methylation, especially promoter hypermethylation, can silence tumor-suppressive miRNAs. Aberrant methylation patterns are associated with CRC development and can be detected even in early or non-invasive samples.\"}]","Micro RNA in Colorectal Cancer—Potential Diagnostic and Prognostic Markers - An Updated Review | PDF",1790178807,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0206d0706a9054be49589161414c26ae.webp",983,1390,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/79363703d3020618b4e9361e025f4b69.webp",982,1388,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7b0170db8413ef2a693923e3aafc44e0.webp",981,1387,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1fef1c67df34c25f3ec8c53f077726da.webp",980,1385]